1 ockout mice, presumably through binding to a heterophile.

2 ystem showed 97% agreement with conventional heterophile and anti-nuclear antigen assays and 92% agre

3 platform compared to results of conventional heterophile and ELISA-based assays.

4 ct of protective HLA alleles associated with heterophile antibodies could explain the previously repo

5 m diabetes and are associated with increased heterophile antibodies is currently unknown.

6 this assay, we have found evidence for human heterophile antibodies mimicking serum IL-4: all serum I

7                   These results suggest that heterophile antibodies represent an in vivo trait associ

8        Patients with cancer have circulating heterophile antibodies that agglutinate animal red cells

9 After adjustment for HLA, positive levels of heterophile antibodies were not associated with protecti

10 ntibodies to the viral capsid antigen (VCA), heterophile antibodies, and IgG antibodies to the EBV ea

11 bodies to malaria and schistosoma parasites, heterophile antibodies, and rheumatoid factor (RF) titer

12  to measure serum IL-4 revealed evidence for heterophile antibodies, i.e., nonanalyte substances in s

13 ent of microvilli, submucosal edema, mucosal heterophile infiltrates, and Shiga toxin-induced vascula

14 ased on whether three (EBV VCA IgG, IgM, and heterophile) or five markers are utilized.